Evidence Hub

Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence

Mohamed Kadry Taher, Talia Salzman, Allyson Banal, Kate Morissette, Francesca R. Domingo, Angela M. Cheung, C. L. Cooper, Laura Boland et al.

Health Promotion and Chronic Disease Prevention in Canada, 2025

2 citations

Abstract

This corrigendum is being published to correct a number of errors and imprecisions, on pages 113, 120-125 and 138, of the following article: Taher MK, Salzman T, Banal A, Morissette K, Domingo FR, Cheung AM, Cooper CL, Boland L, Zuckermann AM, Mullah MA, Laprise C, Colonna R, Hashi A, Rahman P, Collins E, Corrin T, Waddell LA, Pagaduan JE, Ahmad R, Jaramillo Garcia AP. Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence. Health Promot Chronic Dis Prev Can. 2025;45(3):112-38. https://doi.org/10.24095/hpcdp.45.3.02 The authors would like to clarify a few points specifically related to the referencing of results from the 2023 Canadian COVID-19 Antibody and Health Survey (CCAHS).Footnote1 These clarifications reflect refinements in how the source data are interpreted and attributed, and do not affect the core findings or conclusions of the review. Bold has been used to identify the changes and updated text.

How strong is the evidence?

Evidence Hub reads this as a meta-analysis. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free